Literature DB >> 28053747

The growing threat of carbapenem resistant enterobacteriaceae (CRE) within in-patient spinal rehabilitation units.

Priyadarshini Chari1, Anna Seruga1, Nelson Nathan1, David M Bowers1.   

Abstract

This case report highlights the present threat and challenges with treatment and transmission of infections caused by carbepenem-resistant enterobacteriaceae (CRE) within in-patient spinal rehabilitation units. The setting is within the Spinal Cord Injury Unit, Royal North Shore Hospital, Sydney, Australia. We report the case of a 45-year-old female with T9 complete paraplegia who developed CRE urinary tract infection (UTI) and sepsis 1 month post injury while in an in-patient spinal rehabilitation unit. We describe the challenges in treatment with colistin, the implications of infection on her rehabilitation and challenges in containing the spread of CRE to other patients in the unit. We present our experience with the management of CRE bactaeraemia in a spinal rehabilitation unit and the enhanced importance of infection control and surveillance strategies required to successfully contain risk of transmission.

Entities:  

Keywords:  Bacterial infection; Rehabilitation; Urinary tract infection

Year:  2016        PMID: 28053747      PMCID: PMC5129433          DOI: 10.1038/scsandc.2016.3

Source DB:  PubMed          Journal:  Spinal Cord Ser Cases        ISSN: 2058-6124


  9 in total

1.  Multidrug-resistant gram-negative infections. Bringing back the old.

Authors:  Noreen H Chan-Tompkins
Journal:  Crit Care Nurs Q       Date:  2011 Apr-Jun

2.  Risk factors for colonization due to carbapenem-resistant Enterobacteriaceae among patients exposed to long-term acute care and acute care facilities.

Authors:  Ashish Bhargava; Kayoko Hayakawa; Ethan Silverman; Samran Haider; Krishna Chaitanya Alluri; Satya Datla; Sreelatha Diviti; Vamsi Kuchipudi; Kalyan Srinivas Muppavarapu; Paul R Lephart; Dror Marchaim; Keith S Kaye
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

3.  Challenges in the management of infections due to carbapenem-resistant Enterobacteriaceae.

Authors:  Dimitri M Drekonja; Susan E Beekmann; Sean Elliott; Deepa Mukundan; Hari Polenakovik; Marnie E Rosenthal; Pranita D Tamma; Philip M Polgreen; Scott J Weissman
Journal:  Infect Control Hosp Epidemiol       Date:  2014-04       Impact factor: 3.254

Review 4.  Evolution and epidemiology of extended-spectrum beta-lactamases (ESBLs) and ESBL-producing microorganisms.

Authors:  M Gniadkowski
Journal:  Clin Microbiol Infect       Date:  2001-11       Impact factor: 8.067

5.  Urinary tract infection analysis in a spinal cord injured population undergoing rehabilitation--how to treat?

Authors:  C F Martins; E Bronzatto; J M Neto; G S Magalhães; C A L D'anconna; A Cliquet
Journal:  Spinal Cord       Date:  2012-09-11       Impact factor: 2.772

Review 6.  Antibiotic treatment of infections due to carbapenem-resistant Enterobacteriaceae: systematic evaluation of the available evidence.

Authors:  Matthew E Falagas; Panagiota Lourida; Panagiotis Poulikakos; Petros I Rafailidis; Giannoula S Tansarli
Journal:  Antimicrob Agents Chemother       Date:  2013-09-30       Impact factor: 5.191

Review 7.  Management of urinary tract infection in patients with spinal cord injuries.

Authors:  M E García Leoni; A Esclarín De Ruz
Journal:  Clin Microbiol Infect       Date:  2003-08       Impact factor: 8.067

8.  Epidemiology of hospital-acquired infections in veterans with spinal cord injury and disorder.

Authors:  Charlesnika T Evans; Sherri L LaVela; Frances M Weaver; Michael Priebe; Paul Sandford; Pamela Niemiec; Scott Miskevics; Jorge P Parada
Journal:  Infect Control Hosp Epidemiol       Date:  2008-03       Impact factor: 3.254

Review 9.  Toxicity of polymyxins: a systematic review of the evidence from old and recent studies.

Authors:  Matthew E Falagas; Sofia K Kasiakou
Journal:  Crit Care       Date:  2006-02       Impact factor: 9.097

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.